Trade Summary

1 month ago, TANG KEVIN, serving as Chief Executive Officer at Aurinia Pharmaceuticals Inc. (AUPH), purchased 814,606 shares at $15.29 per share, for a total transaction value of $12,455,227.01. Following this transaction, TANG KEVIN now holds 13,044,106 shares of AUPH.

This purchase represents a 6.66% increase in TANG KEVIN's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 29, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 3, 2026 (accepted Jun 2, 9:54 PM ET), 5 days after the trade was made.

Aurinia Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.